Holdings of Invesco V.I. Health Care Fund
AIM Variable Insurance Funds (Invesco Variable Insurance Funds) · Original filing · Compare with another fund · Report an error
- Net assets
- 148.4M $ including 142.8M $ in equities, 96.2 %
- Positions
- 78 in 6 countries
- Top ten
- 42.2 % of net assets
- Filed on
- Mar 31, 2026
Portfolio shape
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | Eli Lilly & Co | 14,751 | 13.6M $ | 9.14 % |
| 2 | Johnson & Johnson | 35,303 | 8.6M $ | 5.81 % |
| 3 | AstraZeneca PLC | 32,828 | 6.5M $ | 4.36 % |
| 4 | Gilead Sciences Inc | 43,847 | 6.1M $ | 4.12 % |
| 5 | AbbVie Inc | 25,391 | 5.5M $ | 3.72 % |
| 6 | Cencora Inc | 17,242 | 5.4M $ | 3.65 % |
| 7 | McKesson Corp | 6,187 | 5.4M $ | 3.61 % |
| 8 | Argenx SE | 6,892 | 5M $ | 3.39 % |
| 9 | Merck & Co Inc | 27,966 | 3.4M $ | 2.27 % |
| 10 | Welltower Inc | 15,671 | 3.1M $ | 2.09 % |
| 11 | HCA Healthcare Inc | 6,432 | 3M $ | 2.05 % |
| 12 | Vertex Pharmaceuticals Inc | 6,623 | 3M $ | 1.99 % |
| 13 | Royalty Pharma PLC | 57,339 | 2.8M $ | 1.85 % |
| 14 | BrightSpring Health Services Inc | 62,746 | 2.7M $ | 1.80 % |
| 15 | Insmed Inc | 15,670 | 2.6M $ | 1.73 % |
| 16 | Cardinal Health, Inc. | 11,823 | 2.5M $ | 1.68 % |
| 17 | Regeneron Pharmaceuticals, Inc. | 3,228 | 2.5M $ | 1.68 % |
| 18 | Thermo Fisher Scientific Inc | 4,714 | 2.3M $ | 1.56 % |
| 19 | UCB SA | 7,580 | 2.3M $ | 1.54 % |
| 20 | Guardant Health Inc | 24,692 | 2.3M $ | 1.54 % |
| 21 | Natera Inc | 11,191 | 2.2M $ | 1.51 % |
| 22 | IDEXX Laboratories Inc | 3,792 | 2.1M $ | 1.44 % |
| 23 | Bridgebio Pharma Inc | 28,134 | 2.1M $ | 1.41 % |
| 24 | UnitedHealth Group Inc | 7,708 | 2.1M $ | 1.41 % |
| 25 | Axsome Therapeutics Inc | 11,411 | 1.9M $ | 1.30 % |
| 26 | Intuitive Surgical Inc | 3,973 | 1.8M $ | 1.23 % |
| 27 | United Therapeutics Corp | 2,998 | 1.8M $ | 1.20 % |
| 28 | Sandoz Group AG | 22,014 | 1.7M $ | 1.16 % |
| 29 | Mettler-Toledo International Inc | 1,363 | 1.7M $ | 1.16 % |
| 30 | Edwards Lifesciences Corp | 20,667 | 1.7M $ | 1.12 % |
| 31 | Boston Scientific Corp | 26,142 | 1.6M $ | 1.11 % |
| 32 | Ascendis Pharma A/S | 7,074 | 1.6M $ | 1.09 % |
| 33 | Tenet Healthcare Corp | 8,514 | 1.6M $ | 1.08 % |
| 34 | Encompass Health Corp | 15,280 | 1.5M $ | 1.00 % |
| 35 | Madrigal Pharmaceuticals Inc | 2,753 | 1.4M $ | 0.97 % |
| 36 | Protagonist Therapeutics Inc | 13,525 | 1.4M $ | 0.96 % |
| 37 | CVS Health Corp | 19,815 | 1.4M $ | 0.96 % |
| 38 | Medline Inc | 29,508 | 1.3M $ | 0.88 % |
| 39 | Halozyme Therapeutics Inc | 20,180 | 1.3M $ | 0.88 % |
| 40 | Galderma Group AG | 6,470 | 1.3M $ | 0.86 % |
| 41 | Lonza Group AG | 1,915 | 1.2M $ | 0.83 % |
| 42 | Ligand Pharmaceuticals Inc | 5,939 | 1.2M $ | 0.80 % |
| 43 | Ionis Pharmaceuticals Inc | 13,962 | 1M $ | 0.71 % |
| 44 | Globus Medical Inc | 11,395 | 981.8K $ | 0.66 % |
| 45 | STERIS PLC | 4,309 | 952.8K $ | 0.64 % |
| 46 | Labcorp Holdings Inc | 3,544 | 945.6K $ | 0.64 % |
| 47 | Quest Diagnostics Inc | 4,671 | 915.4K $ | 0.62 % |
| 48 | Medpace Holdings Inc | 1,616 | 776K $ | 0.52 % |
| 49 | Alignment Healthcare Inc | 40,222 | 708.7K $ | 0.48 % |
| 50 | Tarsus Pharmaceuticals Inc | 10,074 | 706.7K $ | 0.48 % |
| 51 | Stryker Corp | 2,121 | 696.9K $ | 0.47 % |
| 52 | LeMaitre Vascular Inc | 5,730 | 625.5K $ | 0.42 % |
| 53 | Alnylam Pharmaceuticals Inc | 1,741 | 576K $ | 0.39 % |
| 54 | BEONE MEDICINES LTD | 1,685 | 500.4K $ | 0.34 % |
| 55 | Repligen Corp | 4,183 | 492.8K $ | 0.33 % |
| 56 | IRhythm Holdings Inc | 4,175 | 492.7K $ | 0.33 % |
| 57 | Arrowhead Pharmaceuticals Inc | 7,737 | 485.1K $ | 0.33 % |
| 58 | Twist Bioscience Corp | 9,702 | 461K $ | 0.31 % |
| 59 | Rapport Therapeutics Inc | 14,308 | 447.7K $ | 0.30 % |
| 60 | Nuvalent Inc | 4,325 | 443.1K $ | 0.30 % |
| 61 | RadNet Inc | 7,870 | 439.9K $ | 0.30 % |
| 62 | Revolution Medicines Inc | 4,495 | 437.1K $ | 0.29 % |
| 63 | TransMedics Group Inc | 4,371 | 434.5K $ | 0.29 % |
| 64 | GeneDx Holdings Corp | 6,601 | 423.9K $ | 0.29 % |
| 65 | Cytokinetics Inc | 6,260 | 412.6K $ | 0.28 % |
| 66 | HeartFlow Inc | 15,766 | 383.6K $ | 0.26 % |
| 67 | BioLife Solutions Inc | 19,732 | 376.5K $ | 0.25 % |
| 68 | Cogent Biosciences Inc | 9,662 | 371.9K $ | 0.25 % |
| 69 | Dianthus Therapeutics Inc | 4,361 | 366K $ | 0.25 % |
| 70 | Rhythm Pharmaceuticals Inc | 3,992 | 347.2K $ | 0.23 % |
| 71 | Palvella Therapeutics Inc | 2,691 | 335.4K $ | 0.23 % |
| 72 | HealthEquity Inc | 3,741 | 312.6K $ | 0.21 % |
| 73 | Bio-Techne Corp | 5,823 | 304.3K $ | 0.21 % |
| 74 | Phathom Pharmaceuticals Inc | 24,059 | 267.3K $ | 0.18 % |
| 75 | Caris Life Sciences Inc | 14,375 | 257K $ | 0.17 % |
| 76 | Mirum Pharmaceuticals Inc | 2,424 | 223.9K $ | 0.15 % |
| 77 | Charles River Laboratories International Inc | 964 | 166.3K $ | 0.11 % |
| 78 | Billiontoone Inc | 1,921 | 151.6K $ | 0.10 % |
Sector breakdown
- Health care 69.3 %
- Real estate 2.2 %
- Unattributed 28.5 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
- USD 95.4 %
- CHF 3.0 %
- EUR 1.6 %
The quoted currency of each line, as declared.
Country breakdown
- United States 86.3 %
- United Kingdom 4.5 %
- Netherlands 3.5 %
- Switzerland 3.0 %
- Belgium 1.6 %
- Denmark 1.1 %
Shares computed on the equity sleeve.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | United States | 71 | 123.2M $ | 86.25 % |
| 2 | United Kingdom | 1 | 6.5M $ | 4.53 % |
| 3 | Netherlands | 1 | 5M $ | 3.52 % |
| 4 | Switzerland | 3 | 4.2M $ | 2.96 % |
| 5 | Belgium | 1 | 2.3M $ | 1.60 % |
| 6 | Denmark | 1 | 1.6M $ | 1.13 % |
Cite this page
Titelia. "Holdings of Invesco V.I. Health Care Fund". https://titelia.com/en/funds/S000000193